(Total Views: 652)
Posted On: 01/22/2022 10:28:20 PM
Post# of 154850
Re: chazzledazzle #115768
chazzle,
I believe Cytodyn is still tracking mTNBC patients, but to move the needly with the FDA, a new data analysis and submission will be needed. I have no way of knowing if mOS has yet to be reached.
It is likely that additional submission would not be made until data available at six months from the previous analysis. That would likely be a significant change in data / survival from the previous submission.
I believe Cytodyn is still tracking mTNBC patients, but to move the needly with the FDA, a new data analysis and submission will be needed. I have no way of knowing if mOS has yet to be reached.
It is likely that additional submission would not be made until data available at six months from the previous analysis. That would likely be a significant change in data / survival from the previous submission.
(3)
(0)
